Cargando…

Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique with substantial evidence for its safety and tolerability in adults. However, less than 5% of published tDCS research is in pediatrics. Our primary objective was to investigate tDCS safety, tolerability, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchanan, Derrick M., Amare, Sarah, Gaumond, Genevieve, D’Angiulli, Amedeo, Robaey, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342754/
https://www.ncbi.nlm.nih.gov/pubmed/37445385
http://dx.doi.org/10.3390/jcm12134346
_version_ 1785072574881857536
author Buchanan, Derrick M.
Amare, Sarah
Gaumond, Genevieve
D’Angiulli, Amedeo
Robaey, Philippe
author_facet Buchanan, Derrick M.
Amare, Sarah
Gaumond, Genevieve
D’Angiulli, Amedeo
Robaey, Philippe
author_sort Buchanan, Derrick M.
collection PubMed
description Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique with substantial evidence for its safety and tolerability in adults. However, less than 5% of published tDCS research is in pediatrics. Our primary objective was to investigate tDCS safety, tolerability, and acceptability in a sample of children and adults. We hypothesized that children and adults would be equal with regard to tDCS safety, tolerability, and acceptability. We tested this hypothesis using a Bayesian approach. Sixty participants aged 6–45 (balanced for sex) participated in a randomized double-blind controlled trial. They were randomly assigned to two ten-minute tDCS sessions with varying amperages and electrode locations. The primary outcome measure of this study was the intensity of 13 potential side effects evaluated at six different time points spanning two weeks. Independent sample Bayes factor tests were conducted between children/adults, males/females, clinical/healthy, and low/high amperage groups. As predicted, there was moderate support for the null hypothesis in all between-group analyses. There were no serious adverse events or dropouts, and the number needed to treat for an additional harmful outcome was 23. This study provided evidence supporting the overall short-term safety, tolerability, and acceptability of tDCS including amperages up to 2 mA and different electrode placements.
format Online
Article
Text
id pubmed-10342754
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103427542023-07-14 Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study Buchanan, Derrick M. Amare, Sarah Gaumond, Genevieve D’Angiulli, Amedeo Robaey, Philippe J Clin Med Article Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique with substantial evidence for its safety and tolerability in adults. However, less than 5% of published tDCS research is in pediatrics. Our primary objective was to investigate tDCS safety, tolerability, and acceptability in a sample of children and adults. We hypothesized that children and adults would be equal with regard to tDCS safety, tolerability, and acceptability. We tested this hypothesis using a Bayesian approach. Sixty participants aged 6–45 (balanced for sex) participated in a randomized double-blind controlled trial. They were randomly assigned to two ten-minute tDCS sessions with varying amperages and electrode locations. The primary outcome measure of this study was the intensity of 13 potential side effects evaluated at six different time points spanning two weeks. Independent sample Bayes factor tests were conducted between children/adults, males/females, clinical/healthy, and low/high amperage groups. As predicted, there was moderate support for the null hypothesis in all between-group analyses. There were no serious adverse events or dropouts, and the number needed to treat for an additional harmful outcome was 23. This study provided evidence supporting the overall short-term safety, tolerability, and acceptability of tDCS including amperages up to 2 mA and different electrode placements. MDPI 2023-06-28 /pmc/articles/PMC10342754/ /pubmed/37445385 http://dx.doi.org/10.3390/jcm12134346 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Buchanan, Derrick M.
Amare, Sarah
Gaumond, Genevieve
D’Angiulli, Amedeo
Robaey, Philippe
Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study
title Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study
title_full Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study
title_fullStr Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study
title_full_unstemmed Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study
title_short Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study
title_sort safety and tolerability of tdcs across different ages, sexes, diagnoses, and amperages: a randomized double-blind controlled study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342754/
https://www.ncbi.nlm.nih.gov/pubmed/37445385
http://dx.doi.org/10.3390/jcm12134346
work_keys_str_mv AT buchananderrickm safetyandtolerabilityoftdcsacrossdifferentagessexesdiagnosesandamperagesarandomizeddoubleblindcontrolledstudy
AT amaresarah safetyandtolerabilityoftdcsacrossdifferentagessexesdiagnosesandamperagesarandomizeddoubleblindcontrolledstudy
AT gaumondgenevieve safetyandtolerabilityoftdcsacrossdifferentagessexesdiagnosesandamperagesarandomizeddoubleblindcontrolledstudy
AT dangiulliamedeo safetyandtolerabilityoftdcsacrossdifferentagessexesdiagnosesandamperagesarandomizeddoubleblindcontrolledstudy
AT robaeyphilippe safetyandtolerabilityoftdcsacrossdifferentagessexesdiagnosesandamperagesarandomizeddoubleblindcontrolledstudy